|
Scanadu is a Silicon Valley-based company that makes medical technology devices for consumers. It was founded some time before January 2011 by Walter De Brouwer, Sam De Brouwer and Misha Chellam in Silicon Valley. In mid 2011, Scanadu set up a lab at NASA Ames Research Center in Mountain View, Calif., to help grow the company.〔 A prototype of Scanadu’s first product, the Scanadu Scout, was unveiled on November 29, 2012. The Scanadu Scout is a portable electronic device for consumer use designed to measure different physiological parameters, including temperature, heart rate, blood oxygenation, respiratory rate, ECG, and diastolic/systolic blood pressure. The device’s expected price will be around $199. Scanadu’s goal was to make the Scanadu Scout available by March 2014 to those who preordered it through Indiegogo and afterwards, to general consumers by Q1 of 2015. Scanadu is seeking approval by the U.S. Food and Drug Administration (FDA) for the device before bringing it to market to ensure clinical-grade accuracy. Scanadu missed the initial shipping deadline; the devices finally began shipping in February 2015.〔https://www.scanadu.com/blog/shipping-has-begun/〕 ==Products== On November 29, 2012, the company unveiled a suite of new tools to “revolutionize consumer healthcare.” The Scanadu Scout is a lightweight device that is touched to a patient’s temple and is touted as being able to return key vital sign results in less than 10 seconds. Project ScanaFlo is a urinanalysis test for conditions like preeclampsia, gestational diabetes, kidney failure and urinary tract infections. Project ScanaFlu is used when a patient is exhibiting cold-like symptoms. The saliva test checks for Strep A, Influenza A and B, adenovirus, and RSV.〔 The suite of products, originally conceived of in partnership with IDEO, is being designed by award-winning industrial designer Yves Behar. Scanadu’s long-term product vision is to combine a broad array of electrical and biochemical sensors with intelligent algorithms to create a real-life Tricorder. Accordingly, the company is often mentioned as a leading contender for the $10m Qualcomm Tricorder X Prize. Another of Scanadu’s goals is to develop a corps of users willing to share their medical readings, such as heart rates and stress, over many years. The idea is to help enable personalized medicine by generating collective information about the relationships between such readings as respiration, temperature and oxygen intake before the onset of a disease.〔 The need for a product like the Scanadu Scout occurred to CEO Walter De Brouwer in 2003 after his five-year-old son fell about 40 feet and lapsed into a coma for 11 weeks.〔 De Brouwer learned that none of his son’s various health data was being consolidated for collective analysis. “To someone from the tech world, this was like something from the dinosaur age,” he told ''The New York Times''.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Scanadu」の詳細全文を読む スポンサード リンク
|